From: Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma
Intensity of immunostaining | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
n° | age | sex | size (cm) | nature of lymph node | CD30 | CD15 | EBV | Versican | Fibulin-1 | Periostin |
HL1 | 19 | M | 1,3 | cervical | + | + | - | +++ | +++ | ++* |
HL2 | 45 | M | 1,7 | cervical | + | + | + | ++* | + | +++* |
HL3 | 21 | F | 2,6 | axillary | + | + | - | -/+ | ++* | ++* |
HL4 | 27 | M | 2,2 | cervical | + | +/- | - | ++* | ++* | +++* |
HL5 | 17 | F | 2,4 | cervical | + | + | - | +++ | + | ++ |
HL6 | 16 | F | 1,6 | jugular | + | - | - | +++ | +++ | +++ |
HL7 | 21 | M | 1,5 | supraclavicular | + | - | - | +++ | +++ | +++ |
HL8 | 27 | M | 3,8 | axillary | +/- | +/- | - | +++ | +++ | +++ |
HL9 | 29 | M | 1 | cervical | + | + | - | +++ | +++ | +++ |
HL10 | 31 | M | 1,5 | mediastinal | + | + | - | ++ | ++ | +++ |
HL11 | 19 | F | 2,5 | cervical | + | +/- | - | ++ | ++ | +++ |
HL12 | 33 | M | 2,1 | cervical | + | +/- | + | +++ | +++ | +++ |
HL13 | 37 | F | 2,5 | supraclavicular | + | +/- | - | ++ | ++ | +++ |
HL14 | 22 | F | 0,8 | cervical | + | +/- | - | + | -/+ | +++ |
HL15 | 20 | M | 3,1 | cervical | + | +/- | + | + | - | ++ |
HL16 | 54 | M | 1 | cervical | + | + | + | -/+ | - | ++ |
HL17 | 33 | F | 1 | supraclavicular | + | + | - | +++ | ++ | ++ |